[Preliminary results of 10 patients with advanced prostatic neoplasm treated with estracyt].
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000000981:diagnostic imaging; D002219:Carbamates / Q000009:adverse effects / Q000627:therapeutic use; D004962:Estranes / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D009943:Organophosphorus Compounds / Q000009:adverse effects / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011859:Radiography
D000970:Antineoplastic Agents; D002219:Carbamates; D004962:Estranes; D009588:Nitrogen Mustard Compounds; D009943:Organophosphorus Compounds
Résultats préliminaires de 10 patients porteurs d'une néoplasie prostatique avancée traités par estracyt